Taho Pharmaceuticals Ltd. (TPEX:6467)

Taho Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2017
Period Ending	Jun 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2017
Market Capitalization	6,834	5,730	2,274	-	-	616
Market Cap Growth	126.17%	151.98%	-	-	-	12.10%
Enterprise Value	6,497	5,343	2,074	-	-	430
Last Close Price	130.50	111.50	44.35	-	-	11.76
PS Ratio	1260.73	681.34	-	-	-	49.65
PB Ratio	17.57	13.52	4.41	-	-	3.55
P/TBV Ratio	17.60	13.55	4.41	-	-	3.94
EV/Sales Ratio	-	635.26	-	-	-	34.70
Debt / Equity Ratio	0.03	0.03	0.03	0.11	-	0.01
Net Debt / Equity Ratio	-0.87	-0.89	-0.93	-1.01	-1.15	-0.74
Net Debt / EBITDA Ratio	1.45	1.75	2.85	1.76	1.84	1.40
Net Debt / FCF Ratio	1.68	1.81	2.89	1.94	1.67	0.92
Asset Turnover	-	0.02	-	0.01	-	0.05
Inventory Turnover	-	-	-	-	-	2.18
Quick Ratio	17.74	15.01	15.02	3.85	2.29	5.13
Current Ratio	17.88	15.12	15.09	3.91	2.39	5.70
Return on Equity (ROE)	-51.38%	-45.62%	-46.32%	-80.79%	-	-56.44%
Return on Assets (ROA)	-	-27.08%	-25.20%	-35.89%	-	-25.53%
Return on Capital Employed (ROCE)	-60.20%	-51.20%	-32.20%	-54.20%	-72.50%	-61.60%
Earnings Yield	-3.40%	-3.74%	-7.36%	-	-	-22.27%
FCF Yield	-2.93%	-3.65%	-7.29%	-	-	-22.48%
Buyback Yield / Dilution	-9.37%	-13.40%	-17.18%	-7.73%	31.26%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 17, 2026

Data Sources Report a data error